Empowering mental health professionals with peer-reviewed psychiatric research and insights

Page 3

More JCP Articles

JCP
Hallucinogen–Psychosis Associations Are Confounded by Baseline Psychiatric History
JCP
County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay
JCP
Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression
JCP
Forty Years at the PTSD Frontier with Barbara O. Rothbaum, PhD
JCP
Prevalence of GLP-1 Receptor Agonist Use Among Privately Insured Individuals with Mood Disorders
JCP
Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms
JCP
National Trends in PTSD among US Military Veterans
JCP
Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs: Practical Notes
JCP
Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide
JCP
Differential Impact of Cholecystokinin and Ghrelin on 2-Year Avoidant/Restrictive Food Intake Disorder Symptoms
JCP
Rethinking Postpartum Depression: Biology, Biomarkers, and New Treatments with Jennifer L. Payne, MD
JCP
NNT, NNH, and LLH for Aripiprazole Once-Monthly in Schizophrenia